Oriole Resources sells Muratdere royalty for US$1.2 million

Oriole Resources has agreed to sell its 1.2% Net Smelter Return royalty in the Muratdere project in Turkey to Ardent Metals for US$1.2 million, with the proceeds supporting the company’s..

Elemental Royalty declares $0.03 quarterly dividend

Elemental Royalty has declared a US$0.03-per-share quarterly dividend, payable on or about October 15, 2026, to shareholders of record on September 30. Eligible registered shareholders may elect to receive the..

Manx Financial Group merges UK finance subsidiaries under Triskel Finance brand

Manx Financial Group is merging three UK finance subsidiaries into Triskel Finance, targeting lower costs, improved revenue focus and a £1.0 million increase in profit before tax by 2028...

Drax upgrades 2026 EBITDA outlook after strong trading and BSIF acquisition

Drax expects 2026 adjusted EBITDA to be around the top of the £680–711 million consensus range, following strong operational performance and the completion of its £561 million acquisition of Bluefield..

Billington wins £42m of data centre contracts

Billington Holdings has secured two significant data centre contracts with new clients, worth around £42 million combined, strengthening its record order book and providing visibility into 2028...

Warpaint London to report Interim Results on 23 September 2026

Warpaint London expects to release its unaudited interim results for the six months ended 30 June 2026 on Wednesday, 23 September 2026...

EDX Medical signs three-year employee health screening deal with Arnold Clark Group

EDX Medical has entered a three-year agreement to provide health and wellbeing screening to Arnold Clark Group employees across the UK, with the contract expected to generate annual revenue of..

Likewise Group to announce Interim Results on 28 September

Likewise Group plc will release its interim results for the six months ended 30 June 2026 on 28 September 2026...

Tern portfolio company Talking Medicines launches ‘Intent to Prescribe’ DrugVoice application

Talking Medicines has launched a new DrugVoice application combining its Message Resonance Score™ with near-real-time point-of-care data to help pharmaceutical companies assess links between HCP message alignment and prescribing intent...

Valeura Energy reports new Gulf of Thailand oil discovery

Valeura Energy has discovered the Suraphi oil field near its Manora operations in the Gulf of Thailand and completed a successful four-well development and appraisal campaign at Jasmine, increasing production..

Criterium Energy: Two Months From a Cash Flow Shift That Could Reframe the Entire Project (video)

Stéphane Foucaud of Auctus Advisors explains why Criterium Energy may be approaching a critical inflection point, with first gas from its Indonesian assets potentially adding meaningful free cash flow, easing..

Cora Gold: Fully Funded Sanankoro Moves From Development Story To Resource Growth Opportunity (video)

Cora Gold CEO Bert Monro discusses the company’s new 12,000-metre drilling campaign at Sanankoro, where the project is now fully funded to production and deposits remain open along strike and..

Corero Network Security: Why DDoS Defence Is Becoming Critical Infrastructure For The AI Era (video)

Corero Network Security CEO Carl Herberger explains why DDoS protection is becoming increasingly vital as AI infrastructure, data centres and digital businesses face faster, more persistent attacks. He also highlights..

Cerillion plc: Record Orders, Omantel Win And A £271m Pipeline Point To A Bigger H2 (video)

Cerillion Plc CEO Louis Hall discusses a record six-month order intake, a 64% jump in the back order book, and why the landmark £42.5m Omantel contract could become a launchpad..

The Diverse Income Trust: Gervais Williams Sees UK Income Stocks Moving From Resilience To Outperformance (video)

Gervais Williams, co-fund manager of The Diverse Income Trust, discusses why UK equity income may be moving into a stronger phase, how geopolitical uncertainty and higher oil prices could affect..

Sintana Energy: Namibia Drilling Window Opens As Chevron, TotalEnergies And Galp Advance The Next Catalysts (video)

Sintana Energy’s Robert Bose and Eytan Uliel discuss the company’s latest funding, the next wave of Namibia activity, Chevron’s upcoming PEL 90 well, progress in Uruguay and why management believes..

Ilika plc: Stereax Revenues Begin as Goliath Finds New Routes Beyond EVs (video)

Ilika Plc (LON:IKA) CEO Graeme Purdy says the company has reached a key commercial inflection point, with Stereax now shipping into medical device supply chains and revenues expected to multiply..

Firering Strategic Minerals: LimeCo Stake Rises as Kilns 3 and 4 Set Up the Next Growth Test (video)

Firering Strategic Minerals is increasing its LimeCo exposure at a crucial stage, with new kilns, higher throughput and a clearer route towards 45% ownership all in focus. Vassilios Carellas explains..

DynaResource: Higher Revenues, New Veins And A 2026 Push To Unlock San José de Gracia’s Bigger Prize (video)

DynaResource President and CEO Rohan Hazelton discusses a stronger Q1 2026, with revenue up to $18 million and adjusted EBITDA reaching $6 million, while setting out how new vein discoveries,..

Manx Financial Group Expands Lending Push with Deposits Up 12% and New Products Incoming (video)

Manx Financial Group says demand for short-term lending products is accelerating as consumers and SMEs navigate economic uncertainty, with deposits rising 12% and Payment Assist delivering 29% growth. Douglas Grant..

METLEN sells Tamarico II solar and battery storage project in Chile

METLEN has agreed to sell the Tamarico II hybrid renewable energy project in Chile’s Atacama Region to Copec Flux. The project combines 165 MW of solar capacity with a 725..

GSK’s Shingrix prefilled syringe approved in Japan

Japan’s health ministry has approved a ready-to-use prefilled syringe presentation of GSK’s Shingrix shingles vaccine, simplifying preparation and administration for healthcare professionals...

AstraZeneca’s Etcamah approved in US for ESR1-mutated advanced breast cancer

The FDA has approved Etcamah (camizestrant) with a CDK4/6 inhibitor for HR-positive, HER2-negative advanced breast cancer after detection of an emerging ESR1 mutation, based on Phase III SERENA-6 results showing..

Standard Life H1 operating profit rises 25% as 2026 targets remain on track

Standard Life reported £563m of adjusted operating profit and £745m of operating cash generation in H1 2026, with all full-year targets on track...

LondonMetric reports £105m of portfolio investment activity

LondonMetric has completed or agreed £105 million of investment activity since July, including £85 million of asset sales, while progressing £140 million of further acquisitions focused on long-let properties...

Ithaca Energy to join FTSE 100 Index

Ithaca Energy has confirmed its promotion to the FTSE 100, effective 21 September 2026, following FTSE Russell’s latest index review...

Oxford Biomedica reports 9% revenue growth as new client wins accelerate

Oxford Biomedica reported H1 2026 revenue of £79.8 million, up 9% year on year, alongside record new client wins and improved adjusted EBITDA. The company reiterated its FY 2026 guidance..

Target Healthcare REIT delivers 12.0% total accounting return as NTA rises 6.4%

Target Healthcare REIT reported its strongest annual financial performance since IPO, with EPRA NTA per share up 6.4%, adjusted earnings per share rising 7.6% and the fully covered annual dividend..

North Atlantic Smaller Companies NAV rises 7.7% in first half

North Atlantic Smaller Companies Investment Trust reported a 7.7% rise in NAV per share to 598.1p for the six months ended 31 July 2026, while its share price increased 18.1%...

Rightmove appoints Rosemary Leith and David Thomas to Board

Rightmove has appointed Rosemary Leith as Senior Independent Director and David Thomas as an Independent Non-Executive Director, strengthening the Board’s technology, governance and property sector expertise...

Unite Group reports 95% occupancy for 2026/27 and reiterates FY2026 guidance

Unite Group has reserved 95% of beds for the 2026/27 academic year, with like-for-like income growth expected at 0.5-1.0%. The company reiterated adjusted EPS guidance of 41.5-43.0p for FY2026...

Drax upgrades 2026 EBITDA outlook after strong trading and BSIF acquisition

Drax expects 2026 adjusted EBITDA to be around the top of the £680–711 million consensus range, following strong operational performance and the completion of its £561 million acquisition of Bluefield..

AIM All Share Index

Trending Last 24 Hours

Search

Currency